Protein may hold promise for diabetes treatment

03/29/2012 | Yahoo!

Researchers at the Gladstone Institutes found that mice genetically engineered to lack a protein called p75 neurotrophin receptor had better insulin response when fed with a normal diet. The mice also showed higher glucose absorption in response to insulin compared with normal mice when the action of the p75NTR protein was blocked in fat cells. "Therapies targeted at p75NTR may represent a new therapeutic approach for diabetes," researcher Katerina Akassoglou reported in the Proceedings of the National Academy of Sciences.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ